D.E. Shaw & Co’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

D.E. Shaw & Co’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-459,500	Closed	-$4.63M	–	5177
2022 Q4	$4.63M	Buy	459,500 +139,076	+43%	+$1.39M	0.01%	2172
2022 Q3	$3.17M	Buy	320,424 +2,858	+0.9%	+$28.2K	﹤0.01%	2579
2022 Q2	$3.11M	Buy	317,566 +30,817	+11%	+$302K	﹤0.01%	2674
2022 Q1	$2.8M	Sell	286,749 -115,506	-29%	-$1.12M	﹤0.01%	2968
2021 Q4	$3.91M	Buy	402,255 +230,190	+134%	+$2.24M	﹤0.01%	2657
2021 Q3	$1.68M	Buy	+172,065	New	+$1.66M	﹤0.01%	3189

D.E. Shaw & Co's MSAC Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 459,500 shares — an estimated $4.63M sold.

D.E. Shaw & Co first reported a position in MSAC in Q3 2021 and held it in 6 quarters. The position peaked at $4.63M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

D.E. Shaw & Co reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
D.E. Shaw & Co sold 459,500 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $4.63M.
D.E. Shaw & Co first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q3 2021 and held it in 6 quarters.
D.E. Shaw & Co's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $4.63M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.